NCT03050554 2024-08-09
SBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC)
University of California, San Diego
Phase 1/2 Terminated
University of California, San Diego
Weill Medical College of Cornell University
University of Rochester
University of Alabama at Birmingham
Memorial Sloan Kettering Cancer Center
University of Utah